Literature DB >> 16352896

Reliability study on the Japanese version of the Clinician's Interview-Based Impression of Change.

Akira Homma1, Yu Nakamura, Shinichi Kobune, Hirofumi Haraguchi, Nobuyoshi Kodani, Isao Takami, Joe Matsuoka, Hiroaki Matsuda, Tadashi Kusunoki.   

Abstract

The Japanese version of the Clinician's Interview-Based Impression of Change (CIBIC-plus J) is a semistructured interview format including a 7-point Likert type scale for the Clinician's Global Impression of Change. It comprises subscales of DAD for ADL, Behave-AD for behavioral and psychiatric symptoms and MENFIS for cognitive and emotional impairment. DAD and Behave-AD are used for caregivers and MENFIS for both caregivers and patients. The objective of this study was to examine the interrater reliability of the CIBIC-plus J by the videotape method. Twenty videotaped patients including 13 real and 7 virtual patients were independently assessed by 11 raters. The kappa coefficient from the full set of data of 20 patients and 11 raters was 0.453, and from the limited data of 13 real patients, 0.383. By permitting one-point disagreements on the 7-point scale or by collapsing it into the 3-point scale (improved, no change, or worsened), kappa improved to 0.894 and 0.731, or 0.734 and 0.504, respectively. From these results, it was concluded that the reliability of a 7-point Clinician's Global Impression of Change was halfway, i.e., neither sufficient nor insufficient. However, if one-point disagreements or collapsing into 3-point scale are allowable, the CIBIC-plus J will be sufficiently reliable.

Entities:  

Mesh:

Year:  2005        PMID: 16352896     DOI: 10.1159/000090296

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  5 in total

1.  Outcome measures for Parkinson's disease dementia: a systematic review.

Authors:  Samantha K Holden; Wallace E Jones; Keith A Baker; Isabel M Boersma; Benzi M Kluger
Journal:  Mov Disord Clin Pract       Date:  2015-09-16

2.  A 24-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of the rivastigmine patch in Japanese patients with Alzheimer's disease.

Authors:  Yu Nakamura; Yukimichi Imai; Masahiro Shigeta; Ana Graf; Toru Shirahase; Hyosung Kim; Akifumi Fujii; Joji Mori; Akira Homma
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-06-24

3.  Does the Use of Nursing-Care Services Reduce the Information about Dementia Patients Provided by Their Caregivers?

Authors:  Yu Nakamura; Akira Homma
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2011-06-24

4.  CIBIC Plus-J Assessment Using a Videotaped Method in Alzheimer's Disease Patients.

Authors:  Yu Nakamura; Mikiko Usui; Takashi Nishikawa; Masashi Takita; Masahiro Shigeta; Yukimichi Imai; Katsuya Urakami; Hiroshi Kita; Akira Homma
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-07-19

5.  Video Rating in Neurodegenerative Disease Clinical Trials: The Experience of PRION-1.

Authors:  Christopher Carswell; Michael Rañopa; Suvankar Pal; Rebecca Macfarlane; Durre Siddique; Dafydd Thomas; Tom Webb; Steve Wroe; Sarah Walker; Janet Darbyshire; John Collinge; Simon Mead; Peter Rudge
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-08-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.